Bausch Health Companies Shareholder Engagement Presentation Deck
●
●
2022 Priorities
12
*****
for
Growth
Accelerate growth engines of
Salix and International
Pharmaceuticals
Stabilize key cash generating
businesses of Derm, Neuro &
Generics
Recovery of procedures in
Asia Pacific, availability of
inventory, and expansion will
support Solta growth
BAUSCH- Health
●
SUSTEET
Focus
Drive operational excellence in
revenue and cost management
to optimize profitability
Achieve timelines and budgets
for key R&D projects
Increase size, breadth, and
depth of product pipeline
through R&D and strategic BD
investments
Performance
Establish high performance,
energized culture with a sense
of urgency, ownership, and
accountability
Develop robust talent
acquisition & development
program that supports
diversity, equity and inclusion
Build fit-for-purpose
organization with new thinking
and capabilities with cost
discipline focus
●
MAR
Unlocking Value
Utilize cash generated from
operations to improve leverage
Flexibility to monetize additional
Bausch+Lomb equity (-8%)
Drive towards target net
leverage ratios ~6.5x-6.7xView entire presentation